Radiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1148/radiol.2392050631
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCarville, M. B.
Right arrow Articles by Kaufman, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCarville, M. B.
Right arrow Articles by Kaufman, R. A.
(Radiology 2006;239:514-520.)
© RSNA, 2006


Pediatric Imaging

Distinguishing Benign from Malignant Pulmonary Nodules with Helical Chest CT in Children with Malignant Solid Tumors1

M. Beth McCarville, MD, Henrique M. Lederman, MD, Victor M. Santana, MD, Najat C. Daw, MD, Stephen J. Shochat, MD, Chin-Shang Li, PhD and Robert A. Kaufman, MD

1 From the Departments of Radiological Sciences (M.B.M., H.M.L., R.A.K.), Hematology-Oncology (V.M.S., N.C.D.), Surgery (S.J.S.), and Biostatistics (C.S.L.), St Jude Children's Research Hospital, 332 N Lauderdale St, Memphis, TN 38105-2794; Department of Diagnostic Imaging, UNIFESP-Escola Paulista de Medicina, Sao Paulo, Brazil (H.M.L.); and University of Tennessee, College of Medicine, Memphis, Tenn (M.B.M., R.A.K., V.M.S., N.C.D., S.J.S.). Received April 15, 2005; revision requested June 14; revision received July 22; final version accepted August 25. Supported in part by Cancer Center Support grant CA21765 from the U.S. Public Health Service and by the American Lebanese Syrian Associated Charities (ALSAC). Address correspondence to M.B.M. (e-mail: beth.mccarville{at}stjude.org).


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
Purpose: To retrospectively assess whether computed tomographic (CT) findings can indicate the benign or malignant nature of pulmonary nodules in pediatric patients with malignant solid primary tumors.

Materials and Methods: With institutional review board approval, waived parental and patient consent, and HIPAA compliance, the authors determined the incidence of malignancy among 81 pulmonary nodules that were sampled at biopsy within 3 weeks after chest CT (January 1999 to September 2003) in 41 young patients with malignant solid tumors. Three radiologists independently and retrospectively reviewed these scans and the available previously obtained scans, classifying nodules as benign, malignant, or indeterminate on the basis of their number, unilateral versus bilateral distribution, size, margins (indistinct vs distinct), calcification, growth, and associated adenopathy. These classifications were compared with nodule histologic type, and interreviewer agreement was assessed.

Results: The median patient age was 14.8 years (mean, 13.7 years; range, 5–21 years). Twenty-four of the 41 patients (58%) had at least one biopsy-proved malignant nodule. Four (10%) patients had both benign and malignant nodules; 17 (42%) had only benign nodules. Reviewer 1 classified 65% (39 of 60) of nodules correctly; reviewer 2, 57% (37 of 65); and reviewer 3, 67% (43 of 64). Interreviewer agreement was slight to moderate ({kappa} ≤ 0.43, P ≤ .03). In contrast to findings in adults, sharply defined nodules in younger individuals were more likely to be malignant (P = .03) and nodule size was not associated with malignancy (P ≥ .32).

Conclusion: The frequency of benign nodules and the inconsistency of predictions based on CT features suggest the need for better predictors of pulmonary nodules being malignant or benign, so as to reduce unnecessary thoracotomy in pediatric patients with solid malignancy.

© RSNA, 2006


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
The development of helical computed tomography (CT) and, more recently, multisection helical CT has improved the quality of chest CT images by diminishing the effects of breathing and cardiac motion (14). A technology that is increasing in clinical use, the picture archiving and communication system (PACS), also offers improved accuracy of interpretation with its image review and analysis functions, especially the window and level adjustment and magnification tools (5,6). While these advances have improved the sensitivity of detection of pulmonary nodules, imaging findings alone often do not indicate the nature of the nodules (1,79).

The CT imaging features of pulmonary nodules have been extensively evaluated in adults but not in children. (Published pediatric reports are cited in references 813.) Because children with malignant solid tumors are at risk of pulmonary metastatic disease, they undergo screening chest CT at diagnosis, throughout treatment, and during routine follow-up. When pulmonary nodules are detected by using CT, an invasive procedure, such as CT-guided needle biopsy or thoracotomy, is usually required to direct subsequent management. These procedures carry known risks and may add unnecessarily to the cost of patient care. Moreover, the number of invasive procedures needed to confirm benign disease should be minimized while diagnosis of malignant nodules is ensured. The purpose of our study, therefore, was to retrospectively assess whether CT findings can indicate the benign or malignant nature of pulmonary nodules in pediatric patients with malignant solid primary tumors.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
Our retrospective study was approved by the institutional review board of St. Jude Children's Research Hospital. Parental and patient informed consent was waived, and the study was performed in compliance with the Health Insurance Portability and Accountability Act. All young patients with malignant solid tumors who underwent biopsy of pulmonary nodules between January 1999 and September 2003 were identified through our solid-tumor data bank. From their medical records, a departmental data manager recorded demographic characteristics; the primary diagnosis; the mode of biopsy (percutaneous or with thoracotomy); and the number, site, and histologic types of the biopsy-sampled nodules. For percutaneous biopsies, the needle gauge and number of passes were also recorded.

CT Scanning Technique
Only those patients in whom prebiopsy imaging was performed at our institution were included in the study. Between January 1999 and February 2002, patients were scanned with a Siemens Plus helical single-section CT scanner (Siemens, Erlangen, Germany) by using a 1:1 pitch. Section thickness was 5 mm for patients younger than 5 years and 8 mm for older patients. Between February 2002 and September 2003, patients were scanned with a LightSpeed Ultra helical eight-row detector CT scanner (GE Medical Systems, Milwaukee, Wis) by using a 5-mm section thickness and a 1.35:1 pitch. All patients were scanned by using 120 kVp with the milliampere-second setting adjusted for body weight. To reduce radiation exposure, after May 2002 we used the auto-milliampere function, presetting the noise level to 5, with the maximum allowable milliampere-second per section based on body weight. Patients able to follow breath-holding instructions (generally aged 6 years and older) were scanned during suspended inspiration. Fifty-five of the 70 scans included in our review were obtained without intravenous contrast agent.

Image Review
CT scans obtained within 3 weeks before the biopsy and the most recent previously obtained CT scans (when available) were retrospectively and independently reviewed by three pediatric radiologists. Reviewer 1 had 9 years of pediatric CT experience, with the most recent 6 years spent in a predominantly pediatric oncology practice setting. Reviewer 2 had 22 years of pediatric CT experience, including oncology. Reviewer 3 had 24 years of pediatric CT experience, with 1 year before this study spent in a predominantly pediatric oncology practice. Reviewers were provided with only the patients' primary diagnosis. All images were reviewed in both the lung and mediastinal windows on a MagicView 1000 PACS workstation (Siemens). Any scans originally archived in only the mediastinal window setting were retrospectively converted to a lung window by using the PACS edge enhancement function; image quality was similar to that of images originally archived in a lung window. The PACS image review functions (including window and level adjustment and magnification tool) were used at the discretion of each reviewer.

To ensure accurate comparisons, before imaging analysis we informed reviewer 1 of the site of each biopsy-sampled nodule as determined from the medical record. This reviewer then numbered the corresponding nodules on the CT images by using the annotation function in the PACS. This numbering system allowed us to accurately track specific nodules among reviewers and to correlate them with their corresponding histologic type. As is our routine practice, reviewers analyzed the CT scans for the total number of nodules present, unilateral versus bilateral distribution, lobar site, mediastinal or hilar adenopathy, presence of lymph node calcification, and development of new nodules since the previous CT scan. The size, margin distinctness (distinct vs indistinct), growth (where applicable), and presence and pattern (central vs other) of calcification of each biopsy-sampled nodule were assessed. Each reviewer subjectively classified the sampled nodules as benign, malignant, or indeterminate on the basis of these features.

Statistical Analyses
We used a logistic regression model with the GENMOD (SAS Institute, Cary, NC) procedure to study the relation between each reviewer's prediction of nodule histologic type and the actual nodule histologic type and to determine the reviewers' ability to predict benign versus malignant histologic type. We used a univariate logistic regression model with the GENMOD procedure to determine the relation between individual imaging parameters and predicted and actual nodule histologic types. To identify combinations of imaging parameters related to predicted or actual nodule histologic type, we first selected candidate imaging parameters that had a significance level of .2 by using a univariate logistic regression model with the GENMOD procedure. We then tested combinations of the selected parameters by using a multivariate logistic regression model with the GENMOD procedure and with a backward elimination procedure. Patients predicted or found to have both benign and malignant nodules were considered to have malignant disease for the purpose of analysis.

Because we expected increasing nodule size and increasing total number of nodules to be predictive of malignant histologic type, we used the Fisher exact test to determine possible threshold values that distinguished benign from malignant histologic type. We used the Cohen {kappa} statistic to determine interreviewer agreement. The exact {chi}2 test was used to compare the incidences of benign and malignant histologic types in the subgroup of patients who had multiple nodules sampled at biopsy. All analyses were performed with StatXact-5 software (Cytel Software, Cambridge, Mass) that was implemented by using SAS, version 9.1 (SAS Institute). P ≤ .05 was considered to indicate a statistically significant difference.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
Patients
Fifty young patients (20 female) underwent biopsy of 104 pulmonary nodules during the study period. The median age was 14.8 years (mean, 13.7 years; range, 5–21 years). Five patients were older than 18 years at the time of diagnosis of their primary tumor. Primary diagnoses were osteosarcoma (n = 30), Wilms tumor (n = 4), melanoma (n = 3), Ewing sarcoma (n = 2), alveolar soft-part sarcoma (n = 2), synovial sarcoma (n = 2), hepatoblastoma (n = 2), hepatocellular carcinoma (n = 1), and other sarcomas (n = 4). There were 47 patients who underwent excisional biopsies (with thoracotomy) and three who underwent CT-guided percutaneous needle biopsies. The percutaneous biopsies were performed by using a coaxial technique with an ASAP automatic 20-gauge core-needle biopsy system (Meditech, Boston Scientific, Watertown, Mass); three to six passes (mean, 4) were made into each nodule. Twenty-eight patients (of 50 [56%]) had at least one biopsy-proved malignant nodule. In 19 patients, multiple nodules were sampled at biopsy; five of them had both benign and malignant nodules. Twenty-two of 50 (44%) patients had only benign nodules (Table 1).


View this table:
[in this window]
[in a new window]

 
Table 1. Histologic Type of 45 Benign Nodules Sampled at Biopsy

 
Nine patients were excluded from imaging review. Five did not undergo the required imaging examination at our institution, two did not undergo chest CT imaging within 3 weeks before biopsy, and two had undergone clinical changes that precluded analysis. One of these two patients had extensive preexisting postoperative lung changes, and one had nodules that had nearly resolved with chemotherapy at the time of prebiopsy CT. In the 41 remaining patients, 81 nodules were sampled with biopsy. Twenty-nine of these patients had comparison CT scans that were obtained 2–12 months (mean, 4.9 months) earlier. Therefore, 70 CT scans (41 obtained within 3 weeks of biopsy and 29 previously obtained comparison scans) of 41 patients with a total of 81 sampled nodules were included in our imaging review. Twenty-four of these 41 patients (58%) had at least one biopsy-proved malignant nodule. In 15 patients, multiple nodules were sampled at biopsy; four of these patients had nodules that were both benign and malignant. Seventeen of the 41 patients (42%) had only benign nodules.

Characterization of Nodules
Of the 70 scans reviewed, 18 had originally been archived in only the mediastinal window setting and were converted to a lung window by using the PACS edge enhancement function. The total number of nodules per patient (biopsy sampled and not biopsy sampled) ranged from one to 13 (mean, 2.3; median, 1), as observed by reviewer 1. None of the reviewers identified all 81 sampled nodules, some of which were identified only at palpation during thoracotomy. Furthermore, each reviewer identified and characterized a slightly different number of nodules. All three reviewers classified the 60 nodules that had originally been labeled by reviewer 1. Reviewer 2 identified an additional five nodules, and reviewer 3 identified an additional four nodules. Therefore, reviewer 1 classified 60 of the 81 sampled nodules, reviewer 2 classified 65, and reviewer 3 classified 64. Because reviewer 2 classified the most nodules, we summarized nodule size on the basis of this reviewer's measurements and found that the median diameter of sampled nodules was 0.4 cm (mean ± standard deviation, 0.64 cm ± 0.086; range, 0.1–3.9 cm). Because nodule size has been shown to be an important indicator of nodule histologic type in adults, we also report the frequency of nodule size measurements for all three reviewers (Table 2).


View this table:
[in this window]
[in a new window]

 
Table 2. Frequency of Nodule Sizes Reported by Each Reviewer

 
Reviewer 1 classified 14 nodules as indeterminate, 19 as benign, and 27 as malignant; 65% (39 of 60) of nodules were correctly classified, with predictive probabilities of 0.93 for malignant nodules and 0.74 for benign nodules. Reviewer 2 classified 11 nodules as indeterminate, one as benign, and 53 as malignant and correctly classified 57% (37 of 65) of nodules; because only one nodule was classified as benign, we could not calculate this reviewer's predictive probability for benign versus malignant histologic type. Reviewer 3 classified five nodules as indeterminate, 15 as benign, and 44 as malignant, correctly classifying 67% (43 of 64), with predictive probabilities of 0.73 for malignant nodules and 0.73 for benign nodules. Interreviewer agreement was slight between reviewers 1 and 2 ({kappa} = 0.15, P = .03), slight between reviewers 2 and 3 ({kappa} = 0.18, P = .02), and moderate between reviewers 1 and 3 ({kappa} = 0.43, P < .001).

Nodule margin distinctness (Table 3) was significantly related to the prediction of malignancy by each of the three reviewers (all P ≤ .02), such that nodules having distinct margins were more likely to be considered malignant than were those having indistinct margins. The development of new nodules since the previous CT scan was a significant predictor of malignant classification by reviewer 3 (P = .02). Hilar adenopathy was significantly associated with the predictions of reviewer 1 (P = .04). This reviewer was more likely to classify nodules as benign when adenopathy was present. None of the other imaging parameters, individually or in combination, was related to a reviewer's prediction of histologic type.


View this table:
[in this window]
[in a new window]

 
Table 3. Imaging Variables as Predictors of Reviewer Classification of Pulmonary Nodule Histologic Type

 
As with the predicted histologic type, distinct nodule margins and the development of new nodules (Table 4) were significantly related to actual histologic type; both factors were predictive of malignancy (P ≤ .03) (Figure). In addition, bilateral nodules were associated with malignancy (P = .04) and a larger number of nodules were marginally associated with malignancy (P = .05). Larger nodule size did not help predict malignancy (P ≥ .37). No combination of imaging variables was related to nodule histologic characteristic for any reviewer.


View this table:
[in this window]
[in a new window]

 
Table 4. Imaging Variables as Predictors of Actual Nodule Histologic Type

 

Figure 1
View larger version (128K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure a: Transverse helical CT images of benign and malignant pulmonary nodules in two young patients with solid malignancies. (a) Image from an 18-year-old male patient with melanoma shows an ill-defined nodule (arrow) that was proved at biopsy to be papillary adenoma. (b) Image from a 12-year-old male patient with osteosarcoma shows a 2-mm sharply defined nodule (arrow) that was proved at biopsy to be metastatic.

 

Figure 1
View larger version (128K):
[in this window]
[in a new window]
[Download PPT slide]
 
Figure b: Transverse helical CT images of benign and malignant pulmonary nodules in two young patients with solid malignancies. (a) Image from an 18-year-old male patient with melanoma shows an ill-defined nodule (arrow) that was proved at biopsy to be papillary adenoma. (b) Image from a 12-year-old male patient with osteosarcoma shows a 2-mm sharply defined nodule (arrow) that was proved at biopsy to be metastatic.

 
Nineteen (38%) of the 50 patients who underwent biopsies (including those whose images were not reviewed) had multiple nodules sampled. Twelve (63%) of the 19 patients had pulmonary metastatic disease, and seven (37%) had only benign nodules. While we found no significant difference between the incidence of benign and malignant histologic findings in this subgroup (P = .36), the small sample size limited our statistical power to detect a significant difference between the incidence of benign and malignant histologic types (95% confidence interval for the difference in the incidence of benign vs malignant nodules: –0.15, 0.68). We found no threshold value for the total number of nodules or for nodule size that distinguished benign from malignant histologic type.


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 
At our large children's cancer hospital, most biopsies of pulmonary nodules in patients with malignant solid tumors (47 of 50 [94%]) were performed at thoracotomy during the study period. Many patients were found to have only benign nodules (22 of 50 [44%]) or to have both benign and malignant nodules (5 of 50 [10%]). The incidences and causes of benign pulmonary nodules among children with cancer differ with geographic region and institutional referral patterns. At our institution, patients are often referred for treatment of solid malignancies that are advanced or refractory to conventional therapy. Despite this selection bias, benign pulmonary nodules were fairly common. In other practice settings, benign nodules in this patient population may be more prevalent. Because histoplasmosis is endemic in our region, a high percentage of benign nodules were due to this granulomatous disease. Such endemic pathogens are likely to influence radiologists' impressions of pulmonary nodules in children with cancer and may affect the proportion of benign versus malignant nodules. These factors should be considered when the risk of nodule biopsy (usually by thoracotomy) is weighed against control of the underlying malignancy.

We found that three experienced pediatric radiologists were able to correctly predict nodule histologic type on the basis of CT imaging parameters in only 57%–67% of cases. All three radiologists classified a considerable number of nodules (8%–23%) as indeterminate. Furthermore, interreviewer agreement was only slight to moderate; the greatest agreement was seen between two radiologists whose practice is predominantly oncologic. The ability of these two radiologists to predict benign histologic type was somewhat superior to that of a radiologist whose practice is primarily in general pediatrics. This finding, although not surprising, is noteworthy because most radiologists who interpret the chest CT scans of pediatric oncology patients practice in either a general pediatric or a combined adult-pediatric setting.

Of nine imaging parameters evaluated, only the distinctness of nodule margins and the development of new nodules were significantly related to the radiologists' interpretations. All three radiologists were more likely to predict malignancy if nodule margins were sharply defined. In adults, however, nodules with sharply defined margins are more often benign, and those with irregular or spiculated margins are usually malignant (1418). We speculate that this difference partly reflects the fact that malignant pulmonary nodules in adults are often primary lung cancers, whereas those in children are almost always metastases. It is also possible that the biologic behavior of primary tumors that metastasize to the lungs differs in these age groups. Of note, all three study radiologists relied on this imaging feature to distinguish benign from malignant nodules, despite the lack of scientific rationale and despite reports to the contrary in the adult literature. This finding underscores the importance of the individual radiologist's experience and highlights the need for additional rigorous investigation of pulmonary nodules in children.

We expected the size and number of nodules to be predictive of histologic type. In a large study conducted by Ginsberg et al (19) and involving 315 adults with cancer, nodules 0.5 cm or smaller were significantly more likely to be benign than larger nodules. Very small (<0.5 cm) pulmonary nodules, often referred to as "ditzels," are especially problematic in pediatric oncology because current imaging technologies depict them more easily, yet size has not been found to be predictive of histologic type (1,20,21). Our findings are in agreement with those of Robertson et al (12), who found that in children with cancer, nodules less than 0.5 cm in diameter were as likely to be malignant as larger nodules. In adults, multiple nodules may indicate a greater likelihood of pulmonary metastatic disease (22). We found that for one reviewer, an increased total number of nodules was only marginally associated with malignancy (P = .05). In our subset of 19 patients who underwent biopsy of multiple nodules, we found no significant difference between the number who had only benign nodules (n = 7) and the number who had metastatic disease (n = 12), although these relatively small subsets limited our statistical power. We also did not find a threshold value for either the size or the number of nodules that statistically distinguished those with benign from those with malignant nodules. Therefore, these imaging parameters appear to have limited predictive value in this patient population.

In adults, pulmonary nodules that remain stable in size for 2 years are highly likely to be benign (1,20,22,23). In our study, 29 of 41 patients had previous CT scans that allowed us to assess nodule growth. Although we found no relation between nodule growth and histologic type, we attribute this finding, in part, to the relatively short intervals between the CT scans (mean, 4.8 months). In addition, there may have been a selection bias: Patients who had significant nodule growth may have been presumed to have metastatic disease without biopsy and therefore would not have been included in our cohort. Although the doubling time of a nodule is undoubtedly an accurate indicator of its histologic type, the clinical usefulness of this information is limited. First, because prompt initiation of therapy is important, observation of potentially metastatic pulmonary nodules over an extended period is not a realistic option. Second, when nodules are very small, it may be difficult to detect an increase in size, even on thin-section CT images: Doubling of the volume of a small nodule only minimally increases the unit of measurement, its diameter. This problem is compounded by the effect of volume averaging, differences in section selection and breath holding between CT examinations, breathing motion artifact, and interreader variability in size measurements (20,24).

A limitation of our study was the somewhat small sample size, which limited our statistical power. We chose our 4-year study period to include only imaging that was performed with a helical CT scanner and archived in our PACS. This restriction allowed us to perform the study in a manner that simulated our current work environment. Another potential limitation was that six of the benign nodules were shown at histologic analysis to be a site of hemorrhage (n = 2) or normal lung (n = 4). It is possible that these represented false-negative findings due to sampling error. However, all but one of these biopsies were performed by using wedge resection, and review of the postoperative chest CT scans revealed no residual nodules in the operative sites.

With the advent of widespread CT screening of adults for lung cancer, a growing body of literature addresses the management of pulmonary nodules in adults. Some investigators suggest that, in this population, no more than 10% of pulmonary nodule biopsies should result in a benign diagnosis (25). Prediction of the likelihood that a nodule is malignant depends on individual patient factors and imaging findings (21,2628). In our cohort, because the likelihood of malignancy was high, a relatively high percentage of patients (44%) underwent biopsy that revealed only benign nodules. Clearly, better methods are needed to discriminate benign from malignant pulmonary nodules in children with malignant solid tumors. We have shown that there are important differences between children and adults regarding the CT imaging features of pulmonary nodules. Specifically, nodules that are sharply defined are more likely to be malignant than benign, and small nodules (≤0.5 cm) are as likely to be malignant as larger nodules. The significance of nodule multiplicity needs to be clarified. There is a crucial need for additional studies that rigorously evaluate the significance of CT imaging features of pulmonary nodules in children to provide a legitimate basis for practice standards. To reduce the number of invasive procedures performed to confirm benign disease, better methods of assessing pulmonary nodules in children should also be sought through additional prospective clinical trials.

We plan to investigate the value of positron emission tomography (PET)-CT in the work-up of pulmonary nodules identified at screening CT in our pediatric patients with solid malignancies. This fusion modality may allow us to more accurately and noninvasively assess the metabolic activity of even small pulmonary nodules, which can be accurately localized on coregistered PET/CT images.


    ADVANCES IN KNOWLEDGE
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 


    FOOTNOTES
 

Abbreviations: PACS = picture archiving and communication system

Author contributions: Guarantor of integrity of entire study, M.B.M.; study concepts/study design or data acquisition or data analysis/interpretation, all authors; manuscript drafting or manuscript revision for important intellectual content, all authors; manuscript final version approval, all authors; literature research, M.B.M., H.M.L., V.M.S., S.J.S.; clinical studies, M.B.M., H.M.L., V.M.S., N.C.D., S.J.S., R.A.K.; statistical analysis, C.S.L.; and manuscript editing, M.B.M., H.M.L., V.M.S., N.C.D., S.J.S., R.A.K.

Authors stated no financial relationship to disclose.


    References
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 ADVANCES IN KNOWLEDGE
 References
 

  1. Munden RF, Hess KR. "Ditzels" on chest CT: survey of members of the Society of Thoracic Radiology. AJR Am J Roentgenol 2001;176:1363–1369.[Abstract/Free Full Text]
  2. Kalender WA, Seissler W, Klotz E, Vock P. Spiral volumetric CT with single-breath-hold technique, continuous transport, and continuous scanner rotation. Radiology 1990;176:181–183.[Abstract/Free Full Text]
  3. Vock P, Soucek M, Daepp M, Kalender WA. Lung: spiral volumetric CT with single-breath-hold technique. Radiology 1990;176:864–867.[Abstract/Free Full Text]
  4. Remy-Jardin M, Remy J, Giraud F, Marquette CH. Pulmonary nodules: detection with thick-section spiral CT versus conventional CT. Radiology 1993;187:513–520.[Abstract/Free Full Text]
  5. Reiner BI, Siegel EL, Hooper FJ. Accuracy of interpretation of CT scans: comparing PACS monitor displays and hard-copy images. AJR Am J Roentgenol 2002;179:1407–1410.[Abstract/Free Full Text]
  6. Pomerantz SM, White CS, Krebs TL, et al. Liver and bone window settings for soft-copy interpretation of chest and abdominal CT. AJR Am J Roentgenol 2000;174:311–314.[Abstract/Free Full Text]
  7. Meisel JA, Guthrie KA, Breslow NE, Donaldson SS, Green DM. Significance and management of computed tomography detected pulmonary nodules: a report from the National Wilms' Tumor Study Group. Int J Radiat Oncol Biol Phys 1999;44:579–585.[CrossRef][Medline]
  8. Owens CM, Veys PA, Pritchard J, Levitt G, Imeson J, Dicks-Mireaux C. Role of chest computed tomography at diagnosis in the management of Wilms' tumor: a study by the United Kingdom Children's Cancer Study Group. J Clin Oncol 2002;20:2768–2773.[Abstract/Free Full Text]
  9. Wootton-Gorges SL, Albano EA, Riggs JM, Ihrke H, Rumack CM, Strain JD. Chest radiography versus chest CT in the evaluation for pulmonary metastases in patients with Wilms' tumor: a retrospective review. Pediatr Radiol 2000;30:533–537.[CrossRef][Medline]
  10. Su WT, Chewning J, Abramson S, et al. Surgical management and outcome of osteosarcoma patients with unilateral pulmonary metastases. J Pediatr Surg 2004;39:418–423.[CrossRef][Medline]
  11. McCarville MB, Kaste SC, Cain AM, Goloubeva O, Rao BN, Pratt CB. Prognostic factors and imaging patterns of recurrent pulmonary nodules after thoracotomy in children with osteosarcoma. Cancer 2001;91:1170–1176.[CrossRef][Medline]
  12. Robertson PL, Boldt DW, De Campo JF. Paediatric pulmonary nodules: a comparison of computed tomography, thoracotomy findings and histology. Clin Radiol 1988;39:607–610.[CrossRef][Medline]
  13. Cohen M, Smith WL, Weetman R, Provisor A. Pulmonary pseudometastases in children with malignant tumors. Radiology 1981;141:371–374.[Free Full Text]
  14. Li F, Sone S, Abe H, Macmahon H, Doi K. Malignant versus benign nodules at CT screening for lung cancer: comparison of thin-section CT findings. Radiology 2004;233:793–798.[Abstract/Free Full Text]
  15. Iwano S, Makino N, Ikeda M, et al. Solitary pulmonary nodules optimal slice thickness of high-resolution CT in differentiating malignant from benign. Clin Imaging 2004;28:322–328.[CrossRef][Medline]
  16. Ost D, Fein A. Management strategies for the solitary pulmonary nodule. Curr Opin Pulm Med 2004;10:272–278.[CrossRef][Medline]
  17. Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med 2003;348:2535–2542.
  18. Bateson EM. An analysis of 155 solitary lung lesions illustrating the differential diagnosis of mixed tumours of the lung. Clin Radiol 1965;16:51–65.[CrossRef][Medline]
  19. Ginsberg MS, Griff SK, Go BD, Yoo HH, Schwartz LH, Panicek DM. Pulmonary nodules resected at video-assisted thoracoscopic surgery: etiology in 426 patients. Radiology 1999;213:277–282.[Abstract/Free Full Text]
  20. Munden RF, Pugatch RD, Liptay MJ, Sugarbaker DJ, Le LU. Small pulmonary lesions detected at CT: clinical importance. Radiology 1997;202:105–110.[Abstract/Free Full Text]
  21. Libby DM, Smith JP, Altorki NK, Pasmantier MW, Yankelevitz D, Henschke CI. Managing the small pulmonary nodule discovered by CT. Chest 2004;125:1522–1529.[Abstract/Free Full Text]
  22. Lillington GA, Caskey CI. Evaluation and management of solitary and multiple pulmonary nodules. Clin Chest Med 1993;14:111–119.[Medline]
  23. Nathan MH, Collins VP, Adams RA. Differentiation of benign and malignant pulmonary nodules by growth rate. Radiology 1962;79:221–232.[Medline]
  24. Zerhouni EA, Stitik FP, Siegelman SS, et al. CT of the pulmonary nodule: a cooperative study. Radiology 1986;160:319–327.[Abstract/Free Full Text]
  25. Cooper JD. Management of the solitary pulmonary nodule: directed resection. Semin Thorac Cardiovasc Surg 2002;14:286–291.[Medline]
  26. Cummings SR, Lillington GA, Richard RJ. Managing solitary pulmonary nodules: the choice of strategy is a "close call." Am Rev Respir Dis 1986;134:453–460.
  27. Jain P, Kathawalla SA, Arroliga AC. Managing solitary pulmonary nodules. Cleve Clin J Med 1998;65:315–326.[Medline]
  28. Godwin JD. The solitary pulmonary nodule. Radiol Clin North Am 1983;21:709–721.[Medline]



eLetters:

Read all eLetters

Distinguishing Benign from Malignant Pulmonary Nodules in Children and in Adults
Denis TACK, et al.
Radiology Online, 27 May 2008 [Full text]

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McCarville, M. B.
Right arrow Articles by Kaufman, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McCarville, M. B.
Right arrow Articles by Kaufman, R. A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
RADIOLOGY RADIOGRAPHICS RSNA JOURNALS ONLINE